BioNTech : Invitation to the Annual General Meeting 2024 - Form 6-K -April 08, 2024 at 05:10 pm EDT : vimarsana.com

Invitation to the Annual General Meeting 2024



Unique identifier of the event: 2008339965e7ee11b53000505696f23c





Ladies and Gentlemen,
...

Related Keywords

Germany , Munich , Bayern , Goldgrube , Hessen , United States , German , American , America , Ugur Sahin , Helmut Jeggle , Ulrich Wandschneider , Sean Marett , Ryan Richardson , Christoph Huber , Michael Motschmann , Nicola Blackwood , Sierk Poetting , Anja Morawietz , Rudolf Staudigl , Schlebusch Weigel , Jens Holstein , Grosse Bleiche , James Ryan , Foundation Repurchase Price , German Stock Corporation Act Akt , Termination Of Service Contract , Company Management Board , Global Health , Development Of The Company Earnings , European Company Se Regulation , Audit Committee , Biontech United Kingdom , Company Do , Governance Committee , Management Board Of Biontech Se Company , European Parliament , Company Goals , Committee Compensation , Meeting Of The Company , Management Board Of The Company , Germany Incorporated Association Institut Der Wirtschaftspr , Stock Option Program , Articles Of Association , Name Of The Program , Mainz Local Court , Adss Of The Company , Bonds , Company Supervisory Board , Articles Of Association Biontech , American Depositary Share Of The Company , Company American Depositary Shares , Institutional Shareholder Services Inc , Computershare Operations Center , Biontech Group , Company For Put Options , Terms Of Management Board Service , Company For Call Options , Restricted Stock Unit Program , Additional Compensation For Committee Activities , Ey Gmbh Co , German Civil Partnership Act Lebenspartnerschaftsgesetz , Melinda Gates Foundation , European Union , Group Of Beneficiaries , Company Articles Of Association , Performance Share Unit Program , Corporate Governance Committee , Mellon Shareowner Services , Terms Of The Current Service Agreements , Nasdaq , German Central Bank Deutsche Bundesbank , Development Of The Compensation , German Stock Corporation Act Aktiengesetz , Audit Firm , American Depositary Shares Of The Company , Product Committee , Stock Exchange , Institute Of Public Auditors , Term Development Of Biontech , Council Regulation Ec No , Annual General Meeting , German Stock Corporation Act , Investor Portal , American Depositary Shares , New York Mellon , Central European Summer Time , Coordinated Universal Time , Supervisory Board , Management Board , Agenda Item , Annual General , Compensation Report , Compensation System , American Depositary Share , Share Ownership Guidelines , Agenda Items , Deputy Chairman , Conditional Capital , Primary Stock Exchange , Issue Date , Maximum Foundation Repurchase , Foundation Repurchase , Put Options , Call Options , Derivative Transactions , Derivative Transaction , Exercise Price , Issue Window , Waiting Period , Allocation Date , Annual General Meetings , German Corporate Governance , Employee Options , Stock Options , Stock Option , Stock Optionsinstead , Absolute Share Price Performance Hurdle , Relative Share Price Performance Hurdle , Relative Price Performance Hurdle , Maximum Term , Waiting Periods , Collaborations Gmbh , Stock Corporation Act , German Corporate Governance Code , German Commercial Code , Chief Legal Officer , Supervisory Board Member , Act Implementing , Second Shareholder Rights Directive , Vice Chair , Management Board Members , System Philosophy , Target Total Compensation , Chief Executive Officer , Stock Option Plans , Stock Option Plan , Current Service Agreements , Management Board Compensation , Performance Share Units , Share Ownership Guideline , Maximum Compensation , Board Grant , Total Compensation , Fringe Benefits , United Kingdom Limited , Term Incentive Compensation , Target Achieve Ment , First Install Ment , Second Install Ment , Corporate Governance , Target Achievement , Target Performance , Management Boards , Corporate Governance Targets , Based Payments , Term Incentive , Employee Stock Ownership Plan , Chief Executive Officer Grant , German Central Bank , Deutsche Bundesbank , Share Based Payment Instruments , Ordinary Shares Underlying Stock , Phantom Stock , Option Exercise Date , Equity Plan , Chief Financial Officer , Management Board Grant , Long Term Incentive , Nasdaq Biotechnology Index , Executive Officer Grant , Stock Ownership Plan , Nasdaq Biotechnology , Public Auditors , Incorporated Association , For James Ryan , United Kingdom , Relative Development , Chief Legal , General Meeting , Remuneration Report , Quality Management , Business Strategy , Long Term Development , Select Market , Regular Review , Temporary Deviation , Target Total Remuneration , Maximum Remuneration , Short Term Incentive , Expense Cap , Fixed Compensation , Variable Compensation Components , Short Term Oriented Variable Compensation , Corporate Goals , Long Term Variable Compensation , Option Performance Period , Allocation Financial Year , Option Issue Date , Exercise Period , Option Issue , Option Exercise , Share Unit Program , Structural Measures , Target Compensation , Successful Management Board , Compensation Components , Related Legal Transactions , Management Board Service Contracts , Contract Termination , German Civil Code , Service Contract , German Civil Partnership Act , Sideline Activities , Ownership Guidelines , These Share Ownership Guidelines , Share Ownership , Supervisory Board Compensation , Corporate Strategy , Supervisory Board Activities , Additional Compensation , Committee Activities , Due Date , Pro Rata Grant , Maximum Limit , Deposit Agreement , Shareowner Services , Council Regulation , European Company , Federal Gazette , General Data Protection Regulation , Markets ,